var data={"title":"Barium: Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Barium: Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/5702?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=barium-patient-drug-information\" class=\"drug drug_patient\">see &quot;Barium: Patient drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F139057\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Bar-Test [DSC];</li>\n      <li>E-Z-Cat Dry;</li>\n      <li>E-Z-Disk;</li>\n      <li>E-Z-Dose;</li>\n      <li>E-Z-HD;</li>\n      <li>E-Z-Paque;</li>\n      <li>E-Z-Paste;</li>\n      <li>Entero VU;</li>\n      <li>Liquid E-Z-Paque;</li>\n      <li>Liquid Polibar Plus;</li>\n      <li>Liquid Polibar [DSC];</li>\n      <li>Polibar ACB [DSC];</li>\n      <li>Readi-Cat 2;</li>\n      <li>Tagitol V;</li>\n      <li>Varibar Honey;</li>\n      <li>Varibar Nectar;</li>\n      <li>Varibar Pudding;</li>\n      <li>Varibar Thin Honey;</li>\n      <li>Varibar Thin Liquid;</li>\n      <li>VoLumen</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F139058\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Radiopaque Agents</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F139049\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Cream, Oral, as sulfate: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">E-Z-Paste: 60% (454 g) [contains methylparaben, propylparaben, saccharin sodium]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Enema, Rectal, as sulfate: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">E-Z-Dose: 105% (650 mL) [contains saccharin sodium, sodium benzoate]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Kit, Rectal, as sulfate: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Polibar ACB: 96% [DSC]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Packet, Oral, as sulfate: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">E-Z-Cat Dry: 2% (50 ea) [contains saccharin sodium]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Paste, Oral, as sulfate: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Varibar Pudding: 40% (230 mL) [contains polysorbate 80, saccharin sodium, sodium benzoate; vanilla flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Suspension, Combination, as sulfate: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Liquid Polibar Plus: 105% (1900 mL) [contains saccharin sodium, sodium benzoate]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Readi-Cat 2: 2.1% (450 mL [DSC]) [contains saccharin sodium, sodium benzoate]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Suspension, Oral, as sulfate: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Entero VU: 24% (600 mL) [contains polysorbate 80, saccharin sodium, sodium benzoate]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Liquid E-Z-Paque: 60% (355 mL, 1900 mL [DSC]) [contains saccharin sodium, sodium benzoate]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Liquid Polibar: 100% (1900 mL [DSC]) [contains saccharin sodium, sodium benzoate]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Readi-Cat 2: 2% (450 mL [DSC]) [contains benzoic acid, saccharin sodium, sodium benzoate]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Readi-Cat 2: 2% (450 mL [DSC]) [contains benzoic acid, saccharin sodium, sodium benzoate; banana smoothie flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Readi-Cat 2: 2% (450 mL) [contains benzoic acid, saccharin sodium, sodium benzoate, sorbitol; banana flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Readi-Cat 2: 2% (450 mL) [contains benzoic acid, saccharin sodium, sodium benzoate, sorbitol; berry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Readi-Cat 2: 2% (450 mL) [contains benzoic acid, saccharin sodium, sodium benzoate, sorbitol; mochaccino flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Readi-Cat 2: 2% (450 mL) [contains benzoic acid, saccharin sodium, sodium benzoate, sorbitol; vanilla flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Readi-Cat 2: 2% (450 mL) [contains saccharin sodium, sodium benzoate, sorbitol; orange flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Readi-Cat 2: 2.1% (450 mL [DSC]) [contains benzoic acid, saccharin sodium, sodium benzoate]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Readi-Cat 2: 2.1% (450 mL) [contains benzoic acid, saccharin sodium, sodium benzoate; berry smoothie flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tagitol V: 40% (60 mL) [contains saccharin sodium, sodium benzoate; apple flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Varibar Honey: 40% (250 mL) [contains polysorbate 80, saccharin sodium, sodium benzoate; apple flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Varibar Nectar: 40% (240 mL) [contains polysorbate 80, saccharin sodium, sodium benzoate; apple flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Varibar Thin Honey: 40% (250 mL) [contains polysorbate 80, saccharin sodium, sodium benzoate; apple flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">VoLumen: 0.1% (450 mL) [contains benzoic acid, saccharin sodium, sodium benzoate; blueberry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Suspension Reconstituted, Oral, as sulfate: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">E-Z-HD: 98% (135 mL) [contains saccharin sodium]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">E-Z-Paque: 96% (176 g, 1200 g [DSC]) [contains propylene glycol, saccharin sodium]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Varibar Thin Liquid: 40% (148 g) [contains polysorbate 80, saccharin sodium]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Tablet, Oral, as sulfate: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Bar-Test: 650 mg [DSC]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">E-Z-Disk: 700 mg</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F139047\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">No</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F46508541\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">Oral, rectal: Refer to individual product labeling for dosage and administration information.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F139050\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Diagnostic aid:</b> Diagnostic aid for computed tomography or x-ray examinations of the GI tract</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50876149\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:2em;margin-right:4em;\">VoLumen may be confused with Voluven</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F139052\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Hypersensitivity to barium or any component of the formulation; gastric or intestinal perforation (known or suspected).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Additional contraindications may vary (refer to specific product labeling):</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Oral formulations: Known obstruction of the GI tract; patients at high risk of GI perforation (eg, recent prior GI perforation, acute GI hemorrhage or ischemia, toxic megacolon, severe ileus, post GI surgery or biopsy, acute GI injury or burn, recent radiotherapy to the pelvis); patients at high risk of aspiration (eg, patients with prior aspiration, tracheoesophageal fistula, obtundation).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Rectal formulations: Toxic megacolon (known or suspected); recent rectal surgery or radiotherapy to the rectum or prostate; use within 6 days of large forceps or &quot;hot&quot; colonic biopsy or a snare polypectomy.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F46508532\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Aspiration: Oral administration of barium is associated with aspiration pneumonitis, especially in patients with a history of food aspiration or with compromised swallowing mechanism. In patients at risk for aspiration, use with caution and begin the procedure with a small volume; some product labeling contraindicates use of oral formulations in patients at high risk of aspiration (refer to specific product labeling). Some oral formulations are not recommended in patients with a history of food aspiration. Monitor patient closely for aspiration; discontinue immediately if aspiration is suspected, and monitor for development of aspiration pneumonitis.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Hypersensitivity: Severe hypersensitivity reactions have been reported; manifestations include hypotension, bronchospasm and other respiratory impairments, and dermal reactions including rashes, urticaria, and itching. A history of bronchial asthma, atopy (as evidenced by hay fever and eczema), food allergies, or a previous reaction to a contrast agent may increase this risk. Emergency equipment and trained personnel should be immediately available and should remain available for at least 30 to 60 minutes following administration (delayed reactions may occur).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Intra-abdominal leakage: Administration may result in leakage of barium at any level of the GI tract in the presence of conditions that increase the risk of perforation such as carcinomas, GI fistula, inflammatory bowel disease, gastric or duodenal ulcer, appendicitis, or diverticulitis, and in patients with a severe stenosis at any level of the GI tract, especially if it is distal to the stomach. The barium leakage has been associated with peritonitis and granuloma formation. Use is contraindicated in patients at high risk of perforation of the GI tract.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Intravasation: Barium may occasionally intravasate into the venous drainage of the large bowel and enter the circulation as a &quot;barium embolus&quot; leading to potentially fatal complications which include systemic and pulmonary embolism, disseminated intravascular coagulation, septicemia, and prolonged severe hypotension. Although this complication is exceedingly uncommon after oral administration of barium, monitor patients for potential intravasation during administration.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Obstruction/baroliths: Oral administration of barium may accumulate proximal to a constricting lesion of the colon, causing obstruction or impaction with development of baroliths (inspissated barium associated with feces) and may lead to abdominal pain, appendicitis, bowel obstruction, or rarely perforation. Patients with the following conditions are at higher risk for developing obstruction or baroliths: Severe stenosis at any level of the GI tract, impaired GI motility, electrolyte imbalance, dehydration, on a low-residue diet, taking medications that delay GI motility, constipation, pediatric patients with cystic fibrosis or Hirschsprung disease, and the elderly. To reduce the risk of delayed GI transit and obstruction, maintain adequate hydration during and in the days following procedure and consider the administration of laxatives.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Disease-related concerns:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Cardiovascular disease: Use with caution in patients with marked hypertension or advanced cardiac disease.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Special populations:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Debilitated patients: Use with caution in debilitated patients.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Dosage form specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Benzyl alcohol and derivatives: Some dosage forms may contain sodium benzoate/benzoic acid; benzoic acid (benzoate) is a metabolite of benzyl alcohol; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&quot;gasping syndrome&quot;) in neonates; the &quot;gasping syndrome&quot; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension and cardiovascular collapse (AAP 1997; CDC 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors 2001); avoid or use dosage forms containing benzyl alcohol derivative with caution in neonates. See manufacturer's labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Polysorbate 80: Some dosage forms may contain polysorbate 80 (also known as Tweens). Hypersensitivity reactions, usually a delayed reaction, have been reported following exposure to pharmaceutical products containing polysorbate 80 in certain individuals (Isaksson 2002; Lucente 2000; Shelley 1995). Thrombocytopenia, ascites, pulmonary deterioration, and renal and hepatic failure have been reported in premature neonates after receiving parenteral products containing polysorbate 80 (Alade 1986; CDC 1984). See manufacturer's labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Propylene glycol: Some dosage forms may contain propylene glycol; large amounts are potentially toxic and have been associated hyperosmolality, lactic acidosis, seizures and respiratory depression; use caution (AAP 1997; Zar 2007). See manufacturer's labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Rectal formulations: Use rectal formulations with caution when obstructive lesions of the colon are suspected; minimize the amount of barium allowed to flow proximal to obstructive lesions of the colon.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Sodium: Some formulations may contain sodium.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Sorbitol: Some formulations may contain sorbitol, which may cause severe reactions (eg, vomiting, hypoglycemia, jaundice, hemorrhage, hepatomegaly, hyperuricemia, kidney failure) in patients with hereditary fructose intolerance; avoid formulations containing sorbitol in patients with hereditary fructose intolerance.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F139054\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Barium is not systemically absorbed; use is not expected to result in exposure to the fetus. In general, elective radiography of the abdomen is avoided during pregnancy but should not be withheld when essential for diagnosis (ACOG 2016).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F139055\" class=\"block brc drugH1Div\"><span class=\"drugH1\">Breast-Feeding Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Barium is not systemically absorbed; use is not expected to result in exposure to a breastfeeding infant.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F46508535\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Barium is an insoluble material that is opaque to x-rays and therefore provides a positive contrast for radiographic studies.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F46508537\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Absorption: None</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Metabolism: Not metabolized</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Excretion: Feces</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16323007\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (E-Z-Paste Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">60% (454 g): $50.83</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Enema</b> (E-Z-Dose Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">105% (650 mL): $34.73</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Pack</b> (E-Z-Cat Dry Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2% (50): $243.43</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Paste</b> (Varibar Pudding Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">40% (230 mL): $60.42</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension</b> (Entero VU Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">24% (600 mL): $37.96</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension</b> (Liquid E-Z-Paque Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">60% (355 mL): $36.97</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension</b> (Liquid Polibar Plus Combination)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">105% (1900 mL): $42.56</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension</b> (Readi-Cat 2 Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2% (450 mL): $4.85</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2.1% (450 mL): $4.85</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension</b> (Tagitol V Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">40% (60 mL): $25.50</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension</b> (Varibar Honey Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">40% (250 mL): $65.79</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension</b> (Varibar Nectar Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">40% (240 mL): $16.76</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension</b> (Varibar Thin Honey Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">40% (250 mL): $65.79</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension</b> (VoLumen Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.1% (450 mL): $8.34</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension (reconstituted)</b> (E-Z-HD Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">98% (135 mL): $6.73</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension (reconstituted)</b> (E-Z-Paque Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">96% (176 g): $4.57</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension (reconstituted)</b> (Varibar Thin Liquid Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">40% (148 g): $6.76</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (E-Z-Disk Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">700 mg (100): $277.56</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F139056\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Barium Sulfuricum (PL);</li>\n      <li>ColomforT Oral (JP);</li>\n      <li>Falibaryt (PL);</li>\n      <li>Micropaque (PL);</li>\n      <li>Microtrast (PL);</li>\n      <li>Prontobario (PL)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. <i>J Pediatr</i>. 2001;139(2):317-319.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/barium-drug-information/abstract-text/11487763/pubmed\" target=\"_blank\" id=\"11487763\">11487763</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Alade SL, Brown RE, Paquet A Jr. Polysorbate 80 and E-Ferol toxicity. <i>Pediatrics</i>. 1986;77(4):593-597.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/barium-drug-information/abstract-text/3960626/pubmed\" target=\"_blank\" id=\"3960626\">3960626</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    American Academy of Pediatrics Committee on Drugs. &quot;Inactive&quot; ingredients in pharmaceutical products: update (subject review). <i>Pediatrics</i>. 1997;99(2):268-278.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/barium-drug-information/abstract-text/9024461/pubmed\" target=\"_blank\" id=\"9024461\">9024461</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    American College of Obstetricians and Gynecologists (ACOG) Committee on Obstetric Practice. Committee Opinion No. 656: Guidelines for diagnostic imaging during pregnancy and lactation. <i>Obstet Gynecol</i>. 2016;127(2):e75-e80.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/barium-drug-information/abstract-text/26942391/pubmed\" target=\"_blank\" id=\"26942391\">26942391</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control and Prevention (CDC). Neonatal deaths associated with use of benzyl alcohol&mdash;United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982;31(22):290-291.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/barium-drug-information/abstract-text/6810084/pubmed\" target=\"_blank\" id=\"6810084\">6810084</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control and Prevention (CDC). Unusual syndrome with fatalities among premature infants: association with a new intravenous vitamin E product. <i>MMWR Morb Mortal Wkly Rep</i>. 1984;33(14):198-199.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/barium-drug-information/abstract-text/6423951/pubmed\" target=\"_blank\" id=\"6423951\">6423951</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    E-Z-Cat Dry (barium sulfate) [prescribing information]. Monroe Township, New Jersey: Bracco Diagnostics; January 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    E-Z-Disk (barium sulfate) [prescribing information]. Monroe Township, New Jersey: Bracco Diagnostics; April 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    E-Z-HD (barium sulfate) [prescribing information]. Monroe Township, New Jersey: Bracco Diagnostics; February 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Isaksson M, Jansson L. Contact allergy to Tween 80 in an inhalation suspension. <i>Contact Dermatitis</i>. 2002;47(5):312-313.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/barium-drug-information/abstract-text/12534540/pubmed\" target=\"_blank\" id=\"12534540\">12534540</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Liquid E-Z-Paque (barium sulfate) [prescribing information]. Monroe Township, New Jersey: Bracco Diagnostics; March 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Lucente P, Iorizzo M, Pazzaglia M. Contact sensitivity to Tween 80 in a child. <i>Contact Dermatitis</i>. 2000;43(3):172.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/barium-drug-information/abstract-text/10985636/pubmed\" target=\"_blank\" id=\"10985636\">10985636</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Readi-Cat 2 and Readi-Cat 2 Smoothie (barium sulfate) [prescribing information]. Monroe Township, NJ: Bracco Diagnostics; February 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Shelley WB, Talanin N, Shelley ED. Polysorbate 80 hypersensitivity. <i>Lancet</i>. 1995;345(8960):1312-1313.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/barium-drug-information/abstract-text/7746084/pubmed\" target=\"_blank\" id=\"7746084\">7746084</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Tagitol V (barium sulfate) [prescribing information]. Monroe Township, New Jersey: Bracco Diagnostics; August 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Varibar Nectar (barium sulfate) [prescribing information]. Monroe Township, NJ: Bracco Diagnostics; July 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Varibar Pudding (barium sulfate) [prescribing information]. Monroe Township, NJ: Bracco Diagnostics; October 2016.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Varibar Thin Honey (barium sulfate) [prescribing information]. Monroe Township, NJ: Bracco Diagnostics; January 2018.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Zar T, Graeber C, Perazella MA. Recognition, treatment, and prevention of propylene glycol toxicity. <i>Semin Dial</i>. 2007;20(3):217-219.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/barium-drug-information/abstract-text/17555487/pubmed\" target=\"_blank\" id=\"17555487\">17555487</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 9180 Version 98.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F139057\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F139058\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F139049\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F139047\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F46508541\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F139050\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F50876149\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F139052\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F46508532\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F139054\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Breast-Feeding Considerations\" href=\"#F139055\" class=\"outlineLink\">Breast-Feeding Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F46508535\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics\" href=\"#F46508537\" class=\"outlineLink\">Pharmacodynamics/Kinetics</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F16323007\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F139056\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/9180|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=barium-patient-drug-information\" class=\"drug drug_patient\">Barium: Patient drug information</a></li></ul></div></div>","javascript":null}